Sveriges mest populära poddar

This Week in Cardiology

Oct 20 2023 This Week in Cardiology

27 min • 20 oktober 2023

Listener feedback, oral anticoagulation in patients with ICH, an example of statistical significance but not clinical significance, and statins and diabetes are the topics John Mandrola, MD, discusses in this week’s podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

https://www.medscape.com/twic

I. Listener Feedback

October 13, 2023 This Week in Cardiology Podcast   https://www.medscape.com/viewarticle/997281

-  European Heart Journal: IVI for PCI   https://doi.org/10.1093/eurheartj/ehad430

-  Elgendy Meta-analysis of Imaging in PCI:   https://www.ahajournals.org/doi/10.1161/CIRCINTERVENTIONS.116.003700

-  ULTIMATE:   https://www.jacc.org/doi/10.1016/j.jacc.2018.09.013

-  ILUMEIN IV: https://www.nejm.org/doi/full/10.1056/NEJMoa2305861

-  OCTOBER:  https://www.nejm.org/doi/full/10.1056/NEJMoa2307770

-  Main STEP-HFpEF paper

-  Letter to the Editor on Lack of Obesity Paradox  https://doi.org/10.1016/j.amjcard.2019.04.037

II. Anticoagulation in ICH

Oral Anticoagulation in ICH Patients With AF: New Data   https://www.medscape.com/viewarticle/997547

-   Lancet Neuro   Meta-analysis https://doi.org/10.1016/S1474-4422(23)00315-0

-   ENRICH AF letter   https://doi.org/10.1016/S0140-6736(23)02025-1

III. Million Hearts

CMS 'Million Hearts' CVD Risk Reduction Model Works   https://www.medscape.com/viewarticle/997551

-   RCT JAMA

IV. Statin Choice and Diabetes

April 7, 2023 This Week in Cardiology Podcast

https://www.medscape.com/viewarticle/990542

-   LODESTAR Main Study

-   LODESTAR Substudy

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

https://www.medscape.com/features/public/machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact [email protected]

00:00 -00:00